Greil, R., Greil-Ressler, S., Weiss, L., Schönlieb, C., Magnes, T., Radl, B., . . . Sordillo, P. P. (2018). A phase 1 dose-escalation study on the safety, tolerability and activity of liposomal curcumin (Lipocurc™) in patients with locally advanced or metastatic cancer. Cancer chemotherapy and pharmacology, 82(4), 695-706. https://doi.org/10.1007/s00280-018-3654-0
Chicago-Zitierstil (17. Ausg.)Greil, Richard, Sigrun Greil-Ressler, Lukas Weiss, Charlotte Schönlieb, Teresa Magnes, Bianca Radl, Gordon T. Bolger, Brigitta Vcelar, und Peter P. Sordillo. "A Phase 1 Dose-escalation Study on the Safety, Tolerability and Activity of Liposomal Curcumin (Lipocurc™) in Patients with Locally Advanced or Metastatic Cancer." Cancer Chemotherapy and Pharmacology 82, no. 4 (2018): 695-706. https://doi.org/10.1007/s00280-018-3654-0.
MLA-Zitierstil (9. Ausg.)Greil, Richard, et al. "A Phase 1 Dose-escalation Study on the Safety, Tolerability and Activity of Liposomal Curcumin (Lipocurc™) in Patients with Locally Advanced or Metastatic Cancer." Cancer Chemotherapy and Pharmacology, vol. 82, no. 4, 2018, pp. 695-706, https://doi.org/10.1007/s00280-018-3654-0.